Unknown

Dataset Information

0

Depletion of circulating blood NOS3 increases severity of myocardial infarction and left ventricular dysfunction.


ABSTRACT: Nitric oxide (NO) derived from endothelial NO synthase (NOS3) plays a central role in myocardial ischemia/reperfusion (I/R)-injury. Subsets of circulating blood cells, including red blood cells (RBCs), carry a NOS3 and contribute to blood pressure regulation and RBC nitrite/nitrate formation. We hypothesized that the circulating blood born NOS3 also modulates the severity of myocardial infarction in disease models. We cross-transplanted bone marrow in wild-type and NOS3(-/-) mice with wild-type mice, producing chimeras expressing NOS3 only in vascular endothelium (BC-/EC+) or in both blood cells and vascular endothelium (BC+/EC+). After 60-min closed-chest coronary occlusion followed by 24 h reperfusion, cardiac function, infarct size (IS), NOx levels, RBCs NO formation, RBC deformability, and vascular reactivity were assessed. At baseline, BC-/EC+ chimera had lower nitrite levels in blood plasma (BC-/EC+: 2.13 ± 0.27 ?M vs. BC+/EC+ 3.17 ± 0.29 ?M; *p < 0.05), reduced DAF FM associated fluorescence within RBCs (BC-/EC+: 538.4 ± 12.8 mean fluorescence intensity (MFI) vs. BC+/EC+: 619.6 ± 6.9 MFI; ***p < 0.001) and impaired erythrocyte deformability (BC-/EC+: 0.33 ± 0.01 elongation index (EI) vs. BC+/EC+: 0.36 ± 0.06 EI; *p < 0.05), while vascular reactivity remained unaffected. Area at risk did not differ, but infarct size was higher in BC-/EC+ (BC-/EC+: 26 ± 3 %; BC+/EC+: 14 ± 2 %; **p < 0.01), resulting in decreased ejection fraction (BC-/EC+ 46 ± 2 % vs. BC+/EC+: 52 ± 2 %; *p < 0.05) and increased end-systolic volume. Application of the NOS inhibitor S-ethylisothiourea hydrobromide was associated with larger infarct size in BC+/EC+, whereas infarct size in BC-/EC+ mice remained unaffected. Reduced infarct size, preserved cardiac function, NO levels in RBC and RBC deformability suggest a modulating role of circulating NOS3 in an acute model of myocardial I/R in chimeric mice.

SUBMITTER: Merx MW 

PROVIDER: S-EPMC3898535 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Depletion of circulating blood NOS3 increases severity of myocardial infarction and left ventricular dysfunction.

Merx Marc W MW   Gorressen Simone S   van de Sandt Annette M AM   Cortese-Krott Miriam M MM   Ohlig Jan J   Stern Manuel M   Rassaf Tienush T   Gödecke Axel A   Gladwin Mark T MT   Kelm Malte M  

Basic research in cardiology 20131218 1


Nitric oxide (NO) derived from endothelial NO synthase (NOS3) plays a central role in myocardial ischemia/reperfusion (I/R)-injury. Subsets of circulating blood cells, including red blood cells (RBCs), carry a NOS3 and contribute to blood pressure regulation and RBC nitrite/nitrate formation. We hypothesized that the circulating blood born NOS3 also modulates the severity of myocardial infarction in disease models. We cross-transplanted bone marrow in wild-type and NOS3(-/-) mice with wild-type  ...[more]

Similar Datasets

| S-EPMC4397096 | biostudies-literature
| S-EPMC6026144 | biostudies-literature
2019-04-01 | GSE112690 | GEO
| S-EPMC6020713 | biostudies-literature
| S-EPMC4854198 | biostudies-literature
| S-EPMC3500695 | biostudies-literature
| S-EPMC6893492 | biostudies-literature
| S-EPMC7703924 | biostudies-literature
| S-EPMC8284373 | biostudies-literature
| S-EPMC6208878 | biostudies-literature